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ABSTRACT 
 
Studying Regulation of Neu5Ac (Sialic acid) Biosynthesis in Drosophila. (April 2009) 
 
Dheeraj Pandey 
Department of Biochemistry and Biophysics 
Texas A&M University 
 
Research Advisor: Dr. Vlad Panin 
Department of Biochemistry and Biophysics 
 
Glycoconjugates are very important compounds found in all domains of life. They are 
not primary products of genetic code like other structural biomolecules such as proteins 
and nucleic acids. They are product of glycosylation, i.e. addition of sugars to target 
molecules like proteins and lipids. Sialylated glycoconjugates are synthesized when 
sialic acids from donor molecules are transferred to the target molecules by 
sialyltransferase. These sialylated glycoconjugates are involved primarily in mediating 
the cell-cell interaction. Due to their prominent position on cell surface they act as a 
recognition site for various receptors as well as pathogens. Until now, most of the 
research about sialic acids and their functions is limited to deuterostomes. The 
information about the biosynthesis of sialic acid is incomplete and not well studied in 
protostomes. In Drosophila, the GNE enzyme that catalyzes the first two steps of sialic 
acid synthesis in vertebrates, is absent but the sialylated products can be detected in 
small quantities. I studied if an isozyme of GNE is present in Drosophila which catalyzes 
the rate limiting reaction of the glycosylation pathway.  
iv 
 
The results from immunoassay and western blot suggest that recombinant protein is 
being synthesized in the cytosol. At this moment, I am balancing the transgenic flies 
which will be tested for in vivo expression of GNE enzyme. I will perform physical tests 
to check for ectopic expression in these transgenic flies. 
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NOMENCLATURE 
 
Neu5Ac   N-acetylneuraminic Acid 
Neu5Gc    N-glycolylneuraminic Acid 
GNE     UDP-GlcNAc 2-epimerase/ManNac Kinase 
UDP     Uridine Diphosphate 
GlcNAc   N-acetyglucosamine 
N     Amino Group 
C     Carboxyl Group 
CTP   Cytidine 5’-triphosphate 
CMP   Cytidine 5’-monophosphate 
PEP   Phosphoenol Pyruvate 
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CHAPTER I 
INTRODUCTION 
 
Glycosylation is an important biochemical reaction that requires enzyme to add sugars to 
proteins and lipids. The end products of this enzymatic reaction are called 
glycoconjugates. This process contributes to the diversification of biomolecules creating 
a “third language of life" following nucleic acids and proteins (1). Glycosylation is a part 
of set of possible post translational modification in some proteins that is required for 
their proper folding.  
 
Sialylation is a type of Glycosylation in which sialic acid is added to the target molecule 
with the help of enzyme sialyltransferase. Sialic acids are a family of more than 50 
structurally distinct molecules of 9-carbon–alpha-keto acids (2). Unlike most other sugar 
residue of vertebrate-glycocojugates which have five or six-carbon sugar backbone, 
sialic acids are composed of nine carbons (Fig. 1). They are instrumental to the great 
diversity of complex carbohydrates, which are frequently found on the surface of 
secreted glycoproteins and glycolipids (3).  Sialic acids are located at non-reducing end 
of glycans attached to glycoconjugates, and appear  
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largely on cell surface in mammals and other vertebrates (Fig. 2). As a result of their 
location and negative charge, Sialic acids play an important role in mediating cellular  
 recognition and cell adhesion. They are involved in the binding and transport of 
positively charged molecules as well as in attraction and repulsion of cells and molecules 
(4). There is evidence that sialic acids are prominently involved in cell-signaling 
mechanism (1). Other important functions include regulation and turnover of 
glycoprotein, pathogen-host recognition, immune system functioning, and nervous 
system development.  
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The biosynthesis of sialylated glycoconjugates includes a number of enzymatic reactions 
that converts the precursor sugar into a donor molecule which is then used by a 
sialyltransferase for the linkage-specific sialylation of glycoconjugates. In vertebrates, 
UDP-GlcNAc is first epimerized to ManNAc which is then phosphorylated to yield 
ManNAc-6-phosphate by a bifunctional enzyme, UDP-GlcNAc 2-epimerase/ManNAc 
kinase. ManNAc-6-P is then condensed with PEP to give Neu5Ac-9-P catalyzed by 
Neu5Ac-9-P synthetase. Neu5Ac-9-P phosphatase removes the phosphate to yield 
Neu5Ac. Neu5Ac is then converted to active CMP-Neu5Ac using Cytidine 5’-
triphosphate (CTP) by CMP-Neu5Ac synthetase. Finally, Sialtransferase (SialT) 
facilitates the addition of Neu5Ac to acceptor molecules (Fig. 3) 
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Figure 3: Sialylation pathway. D. melanogaster carries most of the enzymes necessary for sialylation except the bifunctional 
enzyme UDP-GlcNAc 2-epimerase/ManNac kinase that is necessary for the conversion of UDP-GlcNAc to ManNac-6-phosphate 
(precursor for Neu5Ac). Adapted from Glycoconj J DOI 10.1007/s10719-008-9154-4. 
 
 
Sialic acid is found mostly in deuterostomes and some bacteria with exception of some 
protostomes. Deuterostomes mainly consists of vertebrates with some higher 
invertebrates like echinoderms. All other invertebrates including molluscs, annelids, and 
insects are protostomes. It may be possible that sialic acids are present in very limited 
quantities and restricted to particular tissues and stages in protostomes and other species 
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that appear to be lacking it. Studies have revealed that the genome of fruit fly 
Drosophila melanogaster lacks some essential genes of enzymes necessary for the 
synthesis of sialic acid (Neu5Ac), but contains several other orthologous genes believed 
to be involved in the downstream reactions in the biochemical pathway (2). Fruit fly is 
used as a model because it has a well studied genetic background for over 100 years. In 
addition, it has only a single copy of sialyltransferase gene compared with the mammals 
which have more than 20 different sialyltransferase.  That makes it easy to study and 
genetically manipulate the biosynthesis pathway of sialylation in D. melanogaster. We 
know that D. melanogaster carries most of the enzymes necessary for sialylation except 
the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNac kinase that is necessary for 
the conversion of UDP-GlcNAc to ManNac-6-phosphate (precursor for Neu5Ac). Since 
the Fruit flies have most of the enzymes including SialT, and the sialylated product has 
been detected using mass spectrometry in very low amounts; it raises the question for 
origination of donor molecule. We are not sure whether D. melanogaster possess another 
non-homologous enzyme for that step, or it uses different precursor to bypass these first 
two steps of sialic acid synthesis. But this step looks like a bottleneck step in D. 
melanogaster sialic acid synthesis, which leads to the scarcity of sialylation. GNE is 
bifunctional enzyme, same as UDP-GlcNAc 2-epimerase/ManNac kinase, with 
characteristics of a fusion protein having N-term epimerase and C-term ManNackinase. 
The mutation in codons 263 to 266 of GNE leads to a disease called Sialuria or French 
type sialuria. It is an autosomal dominant inborn error of metabolism in which the 
feedback control mechanism in the biosynthesis of CMP-Neu5Ac is lost. To date, 7 
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patients have been reported with sialuria; presenting clinical features included mild 
psychomotor delay, coarse face, recurrent upper respiratory tract infections, and 
hepatomegaly (5). 
 
Most of the information about sialylation is obtained from deuterostomes, and the 
evidence of sialylation in protostomes has been scarce. I am interested in finding out 
whether or not the sialylation is evolutionarily conserved. I am also interested in finding 
out its ancient function. For this project, I  introduce a mammalian gene from rat that 
makes GNE enzyme  to D. melanogaster to see if this enzyme can up-regulate the 
sialylation of target molecules, so that it would be easier for us to identify the target 
peptide for sialylation.  
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CHAPTER II 
METHODS 
 
Various biochemical and genetical assessment was employed throughout the length of 
my research. For the first part of my research, recombinant DNA technology was applied 
to insert the gene responsible for GNE enzyme into a vector.  After the recombinant 
plasmid was prepared, it was introduced into Drosophila germ line and its cell culture. 
Second part of research will include biochemical assays to check the expression of the 
target molecules in the cell culture, and look at GNE expression phenotypes in the 
transgenic flies.  
 
Recombination plasmid preparation 
PCR (Polymerase Chain Reaction) was performed to amplify the genes for GNE wild 
type and GNE mutant with primers 5’-CCA CTA GTG TCG ACT GGT ACC GAT 
ATC-3’ and 5’-CGA CGG CCG AGA AGA ACG GGA ATA ACC-3’. Gel 
electrophoresis was performed to check for the PCR products and eluted the appropriate 
DNA fragment of 2.4 kilobases. A digestion was set up for the purified PCR products 
(GNE-wt and GNE-mu) with restriction enzymes Eag I and Bgl II and cloning vector 
p3xFLAG-CMV (Fig: 4)with restriction enzymes Not I and Bgl II. A ligation reaction 
for plasmid vector and insert with T4 ligase was carried out. The vector with insert was 
then introduced into the host cells (Escherichia Coli) using electroporation. The 
transformed cells were then plated on a Petri dish for selection with ampicillin.  Colonies 
  8 
from the transformation was picked up and screened for GNE-wt-FLAG and GNE-mu-
FLAG using PCR. The colonies with right insertions were selected and a mini 
preparation was set up to extract the purified plasmid with gene insert of my interest. 
GNE-wt–p3xFLAG and GNE-mu-p3xFLAG were amplified from CMV vector using 
PCR with primers 5’-GCC TCG AGC ATG GAC TAC AAA GAC CAT GAC GGT G-
3’and 5’-CCA CTA GTG TCG ACT GGT ACC GAT ATC-3’. These inserts with 
3xFLAG tag were re-cloned it into pMK-33 (an insect vector) and pUAST (fig 5) 
expression vectors.  pMK-33 vector was digested with restriction enzymes Xho I and 
SpeI. Likewise pUAST vector was digested with restriction enzymes Xho I and XbaI.  
Both inserts with wild type and mutant variant gene were digested with Xho I and SpeI 
restriction enzymes. Vectors and inserts were then ligated. The constructs were further 
amplified by transformation and DNA purification. The prepared constructs were 
sequenced to check for the inaccuracy or any other mutations that may have resulted 
during cloning process. 
  9 
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Production of stable cell line 
 S2 D. melanogaster cells were transfected with the pMK vector with GNE-wt-
p3xFLAG. The transgenic cells were selected using hygromycin. A transient and an 
stable line of cell culture was maintained. An immunoassay of transient line was 
performed to check for percentage of transformed cells. After several batches of 
selection and passaging, the stable line cells were analyzed for the recombinant protein 
with Western Blot. Various biochemical assays will be performed to check the 
expression of GNE in the recombinant cell cultures. These assays will include, but not 
be limited to α-FLAG immunostaining, and SNA lectin staining.  
 
Production of stable transgenic germ line 
The pUAST vector with GNE-p3xFLAG was inserted into D. Melanogaster germ line 
using P element insertion. Several transgenic lines with probable insertions in different 
sites were received. These lines were crossed with balancer flies with the genotype w-; 
Bl/Cy; T2/T6 to find the physical location of inserts in chromosomes. Two different lines 
with insertion on each of X, 2nd and 3rd chromosomes were selected (total 6 lines). These 
flies will take several generations to be a stable line. Physical and behavioral tests on 
these flies will be performed once balancing process is over. In vivo expression of GNE 
enzyme and its products will be checked using different biochemical assays and mass 
spectrometry. 
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CHAPTER III 
RESULTS 
 
Recombination plasmid preparation  
Gel electrophoresis was performed to check for the PCR products and eluted the 
appropriate DNA fragment of 2.4 kilobases for GNE-wt and GNE-mu (figure 6). DNA 
of interest with vector was extracted from transformed bacterial colonies with vector 
plasmid and insert by gel extraction (Figure 7). GNE with 3xFLAG tag was amplified 
using PCR (Figure 8). The results from digestion with several restriction enzymes gave 
the expected bands with right sizes (Figure 9). It means my insertions were of right size 
and in right orientation. The sequencing results which are not included in these results 
further proved my insertions do not carry unexpected mutations. 
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Fig 7: GNE-3xflag-CMV9  (6.4kb) minipreperation. Lane 1: 1 kb ladder; Lanes 2-4: GNEwt; Lanes 4-6 GNEmu. 1 kb ladder used.  
 
 
 
 
 
 
 
 
 
 
 
A                                            B 
 
Figure 8: PCR of GNE with tag. A) GNEwt; B) GNEmu 
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Figure 9: Digestion to check the vectors and inserts are cloned as desired. A) Lanes 2-6: pUAST- inserts digested with kpn1; Lanes 
7-2: pUAST-inserts digested with EcoR1. B) Lanes 2-5: pMK- inserts digested with xho1 and EcoR1; Lanes 6-10: pMK-inserts 
digested with EcoRV. 1 kb ladder used. 
 
 
 
Immunoassay and Western blot 
The results from immunoassay and western blot suggest that recombinant protein is 
being synthesized in the cytosol (figures 10 and 11). Figure 11 illustrates that GNE 
enzyme is approximately 88 kD (2400 bases/3 *110 Da.). The recombinant protein is 
made even without inducing it with CuSO4. 
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Figure 10: Transfected  S2 cells illuminated with DAPI and Rhodamine simultaneously. Red coloration on cytosol is because of the 
presence of recombinant protein.   
 
 
 
 
 
Figure 11: Western blot results for GNE recombinant protein. Lane 1 ladder (Pre-stained SDS- PAGE STDS); lane 2 S2 pellet, lane 3 
S2 induced pellet, lane 4 GNE transfected S2 pellet, lane 5 GNE transfected S2 induced pellet, lane 6 S2 supernatant, lane 7 S2 
supernatant induced, lane 8 GNE transfected S2 sup, lane 9 GNE transfected S2 sup. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
Results from immunoassay and western blot suggest the GNE enzyme is being produced 
in cell culture. I have yet to perform other biochemical assays to determine if this 
enzyme will indeed up regulate the biochemical synthesis of sialic acid. Once the 
chromosome balancing is over, the expression of GNE enzyme in-vivo will be checked 
by dissecting the Drosophila larval brain. Next part of assay will check for the synthesis 
of ManNac-6-phosphate, which is the product for reaction catalyzed by GNE enzyme. 
This result will conclude that the donor for sialic acid synthesis in drosophila is same as 
in mammals. It would also mean that they have lost this enzyme in evolutionary process. 
On the other hand, if there is no production of ManNac-6 phosphate in transgenic flies, it 
could mean Drosophila by passes first two steps or it has a different donor molecule 
involved in sialic acid synthesis. If the results support my hypothesis, I will introduce 
mutant form of GNE enzyme in which negative feedback has been eliminated. It will 
affect the quantity of sialic acid synthesis because the product will not inhibit enzyme 
from catalyzing first two steps of synthesis, thus increasing the sialylated products.  
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